Compile Data Set for Download or QSAR
Report error Found 2615 for UniProtKB: P13945
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25746(cid_2685 | 2-hydroxy-5-{2-[(2-hydroxy-3-{4-[1-meth...)
Affinity DataKd:  6.46E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25748(ICI 89,406 | 3-(2-{[3-(2-cyanophenoxy)-2-hydroxypr...)
Affinity DataKd:  2.04E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25749(Practolol,(-) | Practolol,(+) | N-{4-[2-hydroxy-3-...)
Affinity DataKd: >1.00E+5nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25750(N-(2-{[(2R)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]a...)
Affinity DataKd:  3.55E+4nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25751(Bisoprolol fumarate | Concor | [2-hydroxy-3-(4-{[2...)
Affinity DataKd:  2.14E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25752([(2S)-3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2...)
Affinity DataKd:  1.07E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25753(Artrenolol | 2-{4-[2-hydroxy-3-(propan-2-ylamino)p...)
Affinity DataKd:  7.76E+4nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25754(2-[4-(2-{[(2R)-2-hydroxy-3-phenoxypropyl]amino}eth...)
Affinity DataKd:  234nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25755(N-{3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propo...)
Affinity DataKd:  3.89E+4nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25756(Betalok | Spesikor | {2-hydroxy-3-[4-(2-methoxyeth...)
Affinity DataKd:  6.92E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25747(4-[3-(tert-butylamino)-2-hydroxypropoxy]-2,3-dihyd...)
Affinity DataKd:  102nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25758(2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amin...)
Affinity DataKd:  661nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25759([3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-met...)
Affinity DataKd:  5nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25760(1-(naphthalen-2-yl)-2-(propan-2-ylamino)ethan-1-ol...)
Affinity DataKd:  1.29E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataKd:  117nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25762(Sotalol,(-) | CHEMBL471 | cid_66245 | Sotalol,(+) ...)
Affinity DataKd:  8.91E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25763(5-[(2R)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl...)
Affinity DataKd:  7.76E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25764(ALPRENOLOL,(-) | CHEMBL266195 | ALPRENOLOL,(+) | A...)
Affinity DataKd:  117nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25765(tert-butyl[3-(2-chloro-5-methylphenoxy)-2-hydroxyp...)
Affinity DataKd:  91nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25766(Corgard | (2R,3S)-5-[3-(tert-butylamino)-2-hydroxy...)
Affinity DataKd:  661nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25767(tert-butyl(2-hydroxy-3-{[4-(morpholin-4-yl)-1,2,5-...)
Affinity DataKd:  158nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25768(ICI 118,551 | 1-[(7-methyl-2,3-dihydro-1H-inden-4-...)
Affinity DataKd:  363nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25769(Levalbuterol | Salbutamol,(+/-) | albuterol | Prov...)
Affinity DataKd:  4.68E+4nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25770(Terbutaline,(+/-) | Brethine | 5-[2-(tert-butylami...)
Affinity DataKd:  1.26E+5nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25771(salmeterol xinafoate | 4-(1-hydroxy-2-{[6-(4-pheny...)
Affinity DataKd:  1.86E+3nMAssay Description:The whole cell-binding studies were undertaken in CHO cell lines stably expressing each beta-adrenoceptor subtype. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2008
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50287797(3-(2-{(R)-2-[2-(3-Chloro-phenyl)-2-hydroxy-ethylam...)
Affinity DataEC50:  2.76E+4nMAssay Description:Compound was tested for its ability to stimulate adenylyl cyclase activity in CHO Beta-3 adrenergic receptor cell membrane.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2010
Entry Details Article

TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50002133((4-{2-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-p...)
Affinity DataEC50:  680nMAssay Description:Compound was tested for its ability to stimulate adenylyl cyclase activity in CHO-beta-3 adrenergic receptor cell membrane.More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2010
Entry Details Article

TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50289569((4-{(R)-2-[(R)-2-(3-Chloro-phenyl)-2-hydroxy-ethyl...)
Affinity DataEC50:  2.64E+3nMAssay Description:Effective concentration for stimulation of adenylyl cyclase activity in CHO-beta3 AR expressing cell membranesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2010
Entry Details Article

TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50289564((R)-1-(3-Chloro-phenyl)-2-{(R)-2-[4-(2-hydroxy-eth...)
Affinity DataEC50:  750nMAssay Description:Effective concentration for stimulation of adenylyl cyclase activity in CHO-beta3 AR expressing cell membranesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2010
Entry Details Article

TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075896(4-(3-Hexyl-2-oxo-imidazolidin-1-yl)-N-{4-[2-(2-hyd...)
Affinity DataEC50:  5.62E+7nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075886(N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  9.99E+6nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075895(N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethy...)
Affinity DataEC50:  2.04E+8nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075891(4-(3-Hexyl-2,4-dioxo-imidazolidin-1-yl)-N-{4-[2-(2...)
Affinity DataEC50:  7.76E+7nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50130949(N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethy...)
Affinity DataEC50:  1.86E+8nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075883(4-(3-Hexyl-4-methyl-2-oxo-2,3-dihydro-imidazol-1-y...)
Affinity DataEC50:  1.23E+7nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075892(N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  2.95E+8nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075912(N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  7.08E+7nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075887(N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-...)
Affinity DataEC50:  6.31E+7nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075888(4-(1-Hexyl-5-oxo-1,5-dihydro-[1,2,4]triazol-4-yl)-...)
Affinity DataEC50:  1.00E+7nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075897(N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethy...)
Affinity DataEC50:  4.57E+8nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50075884(4-(4-Hexyl-5-oxo-4,5-dihydro-[1,2,4]triazol-1-yl)-...)
Affinity DataEC50:  1.66E+8nMAssay Description:In vitro effective concentration against beta-3 adrenergic receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50126064((S)-1-((S)-3-Chloro-phenyl)-2-[2-(1H-indol-3-yl)-1...)
Affinity DataEC50:  3.30E+3nMAssay Description:Agonistic activity against human Beta-3 adrenergic receptor as cAMP accumulation in CHO cells expressing beta3-ARMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50126067((R)-1-((R)-3-Chloro-phenyl)-2-[2-(1H-indol-3-yl)-1...)
Affinity DataEC50:  5.40nMAssay Description:Agonistic activity against human Beta-3 adrenergic receptor as cAMP accumulation in CHO cells expressing beta3-ARMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50126069((3-{2-[(R)-2-((R)-3-Chloro-phenyl)-2-hydroxy-ethyl...)
Affinity DataEC50:  0.0620nMAssay Description:Agonistic activity against human Beta-3 adrenergic receptor as cAMP accumulation in CHO cells expressing beta3-ARMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50126071((R)-1-((R)-3-Chloro-phenyl)-2-[2-(7-methoxy-1H-ind...)
Affinity DataEC50:  0.360nMAssay Description:Agonistic activity against human Beta-3 adrenergic receptor as cAMP accumulation in CHO cells expressing beta3-ARMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50126063(1-(3-Chloro-phenyl)-2-[2-(1H-indol-3-yl)-1-methyl-...)
Affinity DataEC50:  12nMAssay Description:Agonistic activity against human Beta-3 adrenergic receptor by measuring cAMP accumulation in CHO cells expressing Beta-3 adrenergic receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50029051(4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol | ...)
Affinity DataEC50:  6.30nMAssay Description:Agonist activity at human adrenergic beta3 receptor expressed in CHO cells assessed as [3H]cAMP levels by radiolabeled ligand based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50029050(4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2...)
Affinity DataEC50:  49nMAssay Description:Agonist activity at human adrenergic beta3 receptor expressed in CHO cells assessed as [3H]cAMP levels by radiolabeled ligand based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM50375891(CHEMBL402462)
Affinity DataEC50:  3.80nMAssay Description:Agonist activity at human adrenergic beta-3 receptor expressed in CHO cells assessed as cAMP levels by DELFIA methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetBeta-3 adrenergic receptor(Human)
University of Nottingham

LigandPNGBDBM25392(Isoproterenol,(+) | CHEMBL434 | 4-[1-hydroxy-2-(pr...)
Affinity DataEC50:  5.80nMAssay Description:Agonist activity at human adrenergic beta-3 receptor expressed in CHO cells assessed as cAMP levels by DELFIA methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 2615 total ) | Next | Last >>
Jump to: